TIDMSWC

RNS Number : 5095Q

Summerway Capital PLC

26 February 2021

26 February 2021

Summerway Capital Plc

("Summerway" or the "Company")

Result of Annual General Meeting

Following the Annual General Meeting of the Company, which was held earlier today, the Board is pleased to announce that all the ordinary and special resolutions set out in the Notice of General Meeting were duly passed.

Full details of the resolutions passed are set out in the Notice of General Meeting which is available on the Company's website at www.summerwaycapital.co.uk.

 
 Ordinary Resolutions                 Total votes          For           Against 
                                          cast                                          Abstain 
                                                                  %            %             % 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
 1     Presentation of the Accounts    3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To elect Vinodka Murria 
 2.     OBE as a Director              3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To elect Paul Gibson 
 3.     as a Director                  3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To elect Anthony Morris 
 4.     as a Director                  3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To re-elect Benjamin 
 5.     Shaw as a Director             3,390,166    3,389,588   99.98   578   0.02    0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To re-elect David Firth 
 6.     as a Director                  3,390,166    3,389,588   99.98   578   0.02    0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To re-appoint the auditors, 
 7.     RSM UK Audit LLP               3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To authorise the Directors 
        to set the auditors' 
 8.     remuneration                   3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To authorise the allotment 
 9.     of Shares                      3,390,166    3,389,491   99.98   675   0.02    0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
       To approve the Company's 
 10.    investment policy              3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
 
   Special Resolution 
                                     ------------  ----------  ------  ----  -----  -----  ----- 
       To disapply pre-emption 
 11.    rights                         3,390,166    3,390,166    100     0     0      0      0 
      -----------------------------  ------------  ----------  ------  ----  -----  -----  ----- 
 

As at the date of the AGM, the number of issued shares and total voting rights of the Company was 8,033,409 shares in issue. The Company's Articles of Association set out that every member who is present in person or by proxy shall have one vote for every share of which he is the holder on a poll.

Enquiries:

Summerway Capital Plc

Tony Morris (Director) +44 (0) 20 7440 7520

N+1 Singer (Nominated Adviser and Broker)

Sandy Fraser, Amanda Grey +44 (0) 20 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGEAEAKASKFEFA

(END) Dow Jones Newswires

February 26, 2021 05:57 ET (10:57 GMT)

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Celadon Pharmaceuticals Charts.